Posts Tagged With 'Gemphire Therapeutics'

Twilio, Several Other IPOs on Tap This Week

Twilio opened Thursday, June 23, at $15 a share. During intraday trading it surged 92% above that price and closed at $28.79. It’s market cap is valued at $2 billion. As you know, there have been few opportunities for investors to get in on initial public offerings this year. However, that will change next week Continue reading →